Polyvinyl alcohol nanofibers for VOC absorption and pathogen elimination in air filtration

Overview

This technology offers a versatile nanofiber-based air filtration solution built from electrospun polyvinyl alcohol nanofibers (PVA-NFs). The nanofibers are engineered to absorb volatile organic compounds (VOCs) through both physisorption and chemisorption while simultaneously delivering antimicrobial action through embedded drug molecules. Designed for compatibility with existing HEPA filtration equipment, the material can be tuned in pore size and thickness to maintain airflow while capturing airborne contaminants.

The core value proposition is a single filtration medium that addresses two persistent air quality challenges: chemical odor and vapor hazards from VOCs, and biological contamination from airborne pathogens. Potential applications include surgical masks that neutralize the strong odor of methyl methacrylate used in operating rooms, industrial air filters for manufacturing environments, and indoor air quality systems for commercial and residential buildings.

Technical specifications

Material composition and fabrication:

• Polyvinyl alcohol nanofibers produced via electrospinning, yielding high surface area and tunable morphology
• Alcohol functional groups on the polymer backbone enable hydrogen bonding with polar VOCs
• Alkyl groups in the polymer chain support hydrophobic interactions with non-polar VOC molecules
• Electrophilic addition reactions between PVA hydroxyl groups and VOCs enable chemisorption, with metal or organo-catalysts incorporated to accelerate this process

Filtration performance:

• Pore size and thickness can be engineered to allow airflow while maintaining filtration efficiency
• Designed for drop-in compatibility with existing HEPA filtration equipment
• Higher VOC absorption capacity than bulk material due to the high surface area of nanofiber architecture

Pathogen elimination:

• Erythromycin antibiotic has been successfully embedded within the nanofiber matrix
• Drug-loaded nanofibers provide antimicrobial action to complement chemical absorption

Validation status:

• Infrared analysis has confirmed absorption of methyl methacrylate (a model VOC used in surgical bone cement) by PVA-NFs
• Collaboration established with the Director of Orthopedic Research at Providence Hospital to develop surgical mask applications
• Erythromycin embedding demonstrated in laboratory settings

Technology readiness level

The technology is currently at an early-to-mid stage of development. Proof-of-concept has been achieved for VOC absorption (demonstrated with methyl methacrylate via infrared analysis) and for antibiotic embedding (erythromycin). The research team is preparing systematic validation studies that will measure VOC absorption efficiency in both solution and vapor phases, characterize absorption kinetics, and optimize nanofiber thickness and pore size for airflow performance.

Planned analytical techniques include gas chromatography, infrared spectroscopy, nuclear magnetic resonance spectroscopy, spectrophotometry, scanning electron microscopy, elemental analysis, and thermogravimetric analysis. Catalyst incorporation and pathogen-elimination performance will be evaluated in parallel. The active collaboration with a clinical partner for surgical mask development provides a defined pathway toward application-specific validation and potential pilot deployment.